SUMMER MALINA: Open Payments
NPI 1720789407 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,572 in 116 payments from 17 companies in 2025. Trend: 2023 $1,196 · 2024 $1,263 · 2025 $1,572
Food & beverage: $1,572
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 20 | $327 |
| Axsome Therapeutics, Inc. | 25 | $246 |
| Alkermes, Inc. | 30 | $246 |
| Otsuka America Pharmaceutical, Inc. | 11 | $180 |
| JAZZ PHARMACEUTICALS INC. | 6 | $100 |
| E.R. Squibb & Sons, L.L.C. | 6 | $95 |
| Almatica Pharma LLC | 3 | $68 |
| Biogen, Inc. | 3 | $64 |
| ABBVIE INC. | 2 | $61 |
| HARMONY BIOSCIENCES LLC | 2 | $40 |
Products named: CAPLYTA, ARISTADA, Auvelity, REXULTI, XYWAV, COBENFY, Sunosi, LOREEV XR.
Industry payments across NE — which companies pay providers there.
